New Innovation Fund
The New Innovation Fund aims to benefit local R&D in the pharmaceutical sector and to improve market competitiveness. This fund would be a national level fund for R&D focusing on orphan and neglected diseases that would require all beneficiaries to license their technologies to generic manufacturers.
The proponents pose two possibilities—the first offers innovators less project support and a two year monopoly period and the second offers a much higher level of financing but no period of market exclusivity. Resources to support the fund would be collected from licensing royalties, novel taxes, government R&D budgets and voluntary contributions.
Miguel A. Matio and Eduardo Franciosi
|CEWG - New Innovation Fund Part1 - Matio Franciosi.pdf||96.36 KB|
|CEWG - New Innovation Fund Part2 - Matio Franciosi.pdf||168.73 KB|